Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AMF’s investment in LEAX has been completed

As communicated in LEAX Group AB’s (“LEAX” or the “Company”) press release on 1 April 2022, AMF Tjänstepension AB (”AMF”) undertook, pursuant to an investment agreement entered into on 1 April 2022, to invest MSEK 300 in the Company (the “Investment”). In connection therewith, it was also announced that the Company intends to acquire four investment properties which are currently leased by LEAX (the “Property Transaction”) and that the Company in connection with the completion of the Investment intends to initiate an early redemption procedure regarding the Company’s bond loan 2018/2022

Publication of the Annual Report 2021 of Misen Energy AB (publ)

The Annual Report for 2021 has been published today, is attached to this press release and is available in Swedish and English on the company’s website at: http://misenenergy.se/repository/Financial_reports_ENG/Misen_Energy_AR2021_ENG.pdf. The Annual Report for 2021 is also available at the company office at Kungsportsavenyen 32, SE-411 36 Gothenburg Sweden and can be ordered at info@misenenergy.se (%69%6e%66%6f@%6d%69%73%65%6e%65%6e%65%72%67%79.%73%65).

Correction Sedana Medical publishes Annual Report 2021

The correction refers to incorrect reference to the Market Abuse Regulation, which was removed in this press release.In addition to significant events and financial information of 2021, the Annual Report focuses on the strategic priorities and ambitions to introduce inhaled sedation to intensive care. “In 2021, we delivered the highest turnover in our history and made strong progress on both of our main priorities: to execute an excellent launch of Sedaconda (isoflurane) in Europe and to prepare for the important US market”, said Johannes Doll, CEO of Sedana Medical.   The Annual

Valtech welcomes The Berndt Group, a Leader in Digital Health Transformations

New York, April 7th, 2022 -- Valtech, a global business transformation agency, today announced the acquisition of The Berndt Group, Ltd. (TBG), a leading digital customer experience agency focusing on digital transformations.The health industry is transforming and digital is emerging as the primary enabler of more sustainable business models and more meaningful lives. By welcoming TBG, a recognized leader in digital health and a leading Sitecore partner, headquartered in Baltimore, Maryland, Valtech adds further depth to its cross-disciplinary capabilities, facilitating the new normal, at

Heimstaden Bostad 2022 Annual General Meeting

Heimstaden Bostad AB (Publ) has held its Annual General Meeting 2022 and resolved the following:· Adopted the financial statements for the year ending 31 December 2021. · Re-elected Casper von Koskull as Chairman of the Board and Ivar Tollefsen, Stefan Attefall, Axel Brändström, John Giverholt, Frans Heijbel, Birgitta Stenmark, Vibeke Krag and Bente Landsnes as board members. · Resolved on SEK 960,000 fee to the Chairman and SEK 300,000 fee to Bente Landsnes. No fee will be paid to the other members. · Re-appointed Ernst & Young AB as external auditor. · Resolved to pay total

Announcement from the Annual General Meeting of Heimstaden AB (publ)

On 7 April 2022 Heimstaden AB (publ) held its annual general meeting. The shareholders also had the opportunity to vote by post. The annual general meeting mainly resolved upon the following in accordance with the presented proposals.· Adoption of the annual report for 2021 and the proposal for the allocation of profit and dividend in accordance with the proposal. · Re-election of Ivar Tollefsen, John Giverholt, Fredrik Reinfeldt, and Vibeke Krag as members of the board of directors. Ivar Tollefsen was re-elected as chairman of the board of directors. · Adoption of the proposal for

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    07 April 2022 at 17:00  Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Juha Kalliokoski Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 12666/6/7 ____________________________________________ Transaction date: 2022-04-06 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction: RECEIPT OF A SHARE-

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    07 April 2022 at 17:00  Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Marko Lehtonen Position: Chief Financial Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 12667/7/6 ____________________________________________ Transaction date: 2022-04-06 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction: RECEIPT OF A SHARE-BASED

Qualified auditor’s report on the annual and consolidated accounts 2021 of Misen Energy AB (publ)

Auditor's report To the general meeting of the shareholders of Misen Energy AB (publ.)Corporate identity number 556526-3968 Report on the annual accounts and consolidated accounts No statements are made respective statements madeWe have been assigned to perform an audit of the annual accounts and consolidated accounts of Misen Energy AB (publ.) for the financial year 2021. As a result of the significance of the matter described in the "Basis for opinions" section, we are unable to express an opinion on whether the financial statements and consolidated financial statements

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    07 April 2022 at 17:00  Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Marjo Nurmi Position: Other senior manager Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 12673/7/6 ____________________________________________ Transaction date: 2022-04-06 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction: RECEIPT OF A SHARE-BASED

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    07 April 2022 at 17:00  Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Vesa Uotila Position: Other senior manager Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 12676/8/10 ____________________________________________ Transaction date: 2022-04-06 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction: RECEIPT OF A SHARE-BASED

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    07 April 2022 at 17:00  Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kerim Nielsen Position: Other senior manager Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 12678/6/6 ____________________________________________ Transaction date: 2022-04-06 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction: RECEIPT OF A SHARE-BASED

Share-based incentive programme 2022

Vestas Wind Systems A/S, Aarhus, 7 April 2022Company announcement no. 09/2022 The Board of Directors of Vestas Wind Systems A/S has decided to continue the share-based incentive programme for all participants, including all members of Executive Management, and launch a new programme for 2022. The 2022 programme will be based on the terms and conditions governing the restricted performance share programme for the year 2021 and in alignment with Vestas’ Remuneration Policy approved by the Annual General Meeting on 8 April 2021. As previously, the programme is based on restricted

Sean Mcllrath announced as new VP of Americas for Artificial Solutions

Artificial Solutions has named Sean Mcllrath as the new Vice President of Americas, continuing the company’s strong team expansion in 2022.With 20+ years of enterprise experience, Sean McIlrath ’s understanding of AI software operation and keen collaboration skills have made him a leader in B2B sales. A distinguishing component of his professional background is his experience running and building sales GTM for AI, machine learning, and automation service. Sean has 10+ years of experience with AI and cloud-based technology; this level of experience

Veidekke: Ready for Kilen Trade Park in Tønsberg

Veidekke Logistikkbygg and Kilen Syd AS (COOP, Canica and Profier) have after many years of planning and development work finally signed a contract to build the bulk shopping centre Kilen Handelspark in Tønsberg. The Contract is a design and build contract valued at almost NOK 370 million excluding VAT.“Profier and Veidekke started work on the trade park as far back as 2008, so in this case it has been a very long journey from start to finish. Our good partnership has been developed through several other previous projects, including Kilen Bolig that Veidekke built for Profier a few years

Bulletin from the Annual General Meeting of Husqvarna AB (publ)

The AGM of Husqvarna AB (publ) was held on April 7, 2022 Due to the ongoing Covid-19 situation, the AGM was conducted pursuant to a so-called mail-in procedure in accordance with Sec. 22 of the Act regarding temporary exceptions to facilitate the holding of annual general meetings (Sw. lagen (2022:121) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor). Shareholders participated in the meeting by voting or submitting questions in advance on the proposals at the AGM. Adoption of the Income Statements and Balance Sheets, dividend and discharge of

Indutrade acquires PMH International AB

Indutrade has signed an agreement to acquire all shares in the Swedish company PMH International AB, www.pmh.se, www.pmh-hallen.se, with annual sales of approximately SEK 140 million.PMH is a specialised technical trading company operating in the market segments lifting and material handling equipment as well as industrial/storage halls. The company’s broad and deep offering in the area of lifting and material handling includes e.g. swing jib cranes, manual chain blocks, electric lever hoists, pneumatic hoists, vacuum lifters, aluminum profile rails and traverses. PMH offers a total

Arise publishes Annual Report 2021

The Annual Report of Arise AB 2021, is now available on our website www.arise.se   It is sent by post to shareholders who have notified the Company that they wish to receive a copy. Printed copies of the report can be ordered via info@arise.se.   Halmstad, 7 April 2022Arise AB (publ)  For further information, please contact:Per-Erik Eriksson, CEO Arise AB, +46 702 409 902Markus Larsson, CFO Arise AB, +46 735 321 776    This information is information that Arise AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted

Prospective investigator-initiated study for 2 years’ follow-up of Episealer® Talus patients initiated

Episurf Medical (Nasdaq: EPIS B) today announces the initiation of a prospective investigator-initiated study with 2 years’ follow-up of 25 Episealer® Talus patients. The study is performed by a team at Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom, with Mr Karan Malhotra as Principal Investigator. The Royal National Orthopaedic Hospital is the largest orthopaedic hospital in the UK, and regarded as a leader in the field of orthopaedics both in the UK and world-wide. The study will evaluate the clinical performance of the Episealer® Talus implant in patients who

Tongji Hospital selects RayStation

RaySearch Laboratories AB (publ) announces that Mevion China has placed an order for RayStation®* which Mevion China has sold together with Mevion’s HYPERSCAN® proton therapy system to Tongji Hospital in Wuhan in China.RaySearch and Mevion have been collaborating since 2014. Treatment planning for particle treatments (protons/carbon ions/BNCT) is an important focus area for RaySearch and today RayStation has a global market share of more than 50 percent, a position that is further strengthened by the new order. RaySearch has about 70 RayStation customers in China through its own

Everfuel to build heavy-duty hydrogen station in Germany

Herning, Denmark, 7 April, 2022 – Everfuel awarded contract for constructing and commissioning of a heavy-duty hydrogen refuelling station in Wuppertal, Germany. After a European-wide tendering procedure, WSW mobil GmbH has awarded Everfuel GmbH the contract for a hydrogen refuelling station that will serve a fleet of fuel cell buses for public transportation. It is the second contract in Germany for Everfuel GmbH for a hydrogen refuelling station for fuel cell buses since the company was founded at the beginning of 2021 as a wholly owned subsidiary of Everfuel A/S from Denmark. "

Correction: Notice of the Annual General Meeting of Optomed Plc

Optomed Plc         Stock Exchange Release    7 April 2022 at 16.15, Helsinki CORRECTION: NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC Optomed corrects a mistake that was in the notice of the annual general meeting release announced today 7 April 2022. Due to a technical issue, the agenda stated in the original release did not include agenda point 1, Opening of the meeting. The complete release including the correction is below: Notice is given to the shareholders of Optomed Plc (“Optomed” or the “Company”) of the Annual General Meeting to be held on Tuesday, 10 May 2022 at

Sedana Medical publishes Annual Report 2021

Sedana Medical AB (publ) (SEDANA: FN Stockholm) published its Annual Report 2021.In addition to significant events and financial information of 2021, the Annual Report focuses on the strategic priorities and ambitions to introduce inhaled sedation to intensive care. “In 2021, we delivered the highest turnover in our history and made strong progress on both of our main priorities: to execute an excellent launch of Sedaconda (isoflurane) in Europe and to prepare for the important US market”, said Johannes Doll, CEO of Sedana Medical. The Annual Report is available at www.sedanamedical.

BERGENBIO ASA: NOTICE OF ANNUAL GENERAL MEETING

Bergen, Norway – 7 April 2022: BerGenBio ASA (OSE:BGBIO) will be holding its Annual General Meeting virtually on 28 April 2022 at 10:00 hours (CEST).   The notice, power of attorney and proposal from Nomination Committee are attached to this release. The notice will be sent to all registered shareholders and is available on the Company’s website: https://www.bergenbio.com/investors/general-meetings/   All shareholders are encouraged to exercise their shareholder rights, either through advance electronically voting through VPS Investor Services, by using the enclosed proxy form

There are no items matching the current filter
There are no more items matching the current filter
Back to top